gadolinium dtpa has been researched along with paclitaxel in 16 studies
| Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (paclitaxel) | Trials (paclitaxel) | Recent Studies (post-2010) (paclitaxel) |
|---|---|---|---|---|---|
| 12,654 | 664 | 4,051 | 31,874 | 5,729 | 15,395 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (56.25) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Abendschein, DR; Fuhrhop, RW; Karukstis, KK; Lanza, GM; Scherrer, DE; Scott, MJ; Wickline, SA; Winter, PM; Yu, X | 1 |
| Abendschein, DR; Chinen, LK; Fuhrhop, RW; Karukstis, KK; Lanza, GM; Scherrer, DE; Scott, MJ; Wickline, SA; Winter, PM; Yu, X | 1 |
| Baick, CH; Chiou, JY; Fruehauf, JP; Mehta, RS; Nalcioglu, O; Su, MY; Wang, J; Yu, H | 1 |
| Delorme, S; Fink, C; Junkermann, H; Klein, SK; Lüdemann, HP; Sinn, HP; Wasser, K; Zuna, I | 1 |
| Daniels, D; Lidar, Z; Maier, SE; Mardor, Y; Ocherashvilli, A; Orenstein, A; Rahav, O; Ram, Z; Roth, Y; Zauberman, Y | 1 |
| Becker, S; Brix, G; Dellian, M; Eichhorn, ME; Griebel, J; Jauch, KW; Michaelis, U; Ruhstorfer, H; Sauer, B; Strieth, S; Teifel, M; Werner, A | 1 |
| Baick, CH; Butler, JA; Hsiang, DJ; Lane, KT; Mehta, RS; Su, MY; Yamamoto, M | 1 |
| Barsness, GW; Bjarnason, H; Howe, PW; Hunt, C; Mathew, V; McKusick, MA; Misra, S; Pflueger, A; Textor, SC; Thatipelli, MR | 1 |
| Blackwell, KL; Craciunescu, OI; Dewhirst, MW; Jones, EL; Liotcheva, V; Macfall, JR; Prosnitz, LR; Rosen, EL; Samulski, TV; Vujaskovic, Z; Wong, TZ; Yu, D | 1 |
| Bertotto, I; Carbonaro, LA; Martincich, L; Montemurro, F; Ponzone, R; Regge, D; Sardanelli, F | 1 |
| Bahri, S; Butler, JA; Carpenter, PM; Chen, JH; Feig, SA; Hsiang, DJ; Kuzucan, A; Lane, KT; Lin, M; Mehta, RS; Nalcioglu, O; Su, MY; Yu, HJ | 1 |
| Artemov, D; Kato, Y; Zhu, W | 1 |
| Chen, S; Li, H; Liu, M; Ren, L; Zhang, Z; Zhong, J; Zhou, X | 1 |
| Hou, J; Hu, Y; Li, F; Lu, Q; Wang, H; Wang, L; Xiang, W; Yu, X; Zeng, W; Zhang, Z | 1 |
| Dong, Y; Grimm, R; Guo, J; Jiang, L; Kamel, IR; Li, H; Lu, Y; Qin, J; Qu, J; Wang, Z; Yan, X; Zhang, F; Zhang, H; Zhang, S; Zhang, T; Zhang, Z; Zhao, Y | 1 |
| Ge, XL; Liu, XS; Sun, NN; Xu, LL | 1 |
2 trial(s) available for gadolinium dtpa and paclitaxel
| Article | Year |
|---|---|
DCE-MRI parameters have potential to predict response of locally advanced breast cancer patients to neoadjuvant chemotherapy and hyperthermia: a pilot study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Contrast Media; Doxorubicin; Female; Gadolinium DTPA; Humans; Hyperthermia, Induced; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Pilot Projects; Prognosis | 2009 |
Variation of breast vascular maps on dynamic contrast-enhanced MRI after primary chemotherapy of locally advanced breast cancer.
Topics: Adult; Antineoplastic Agents; Breast Neoplasms; Carcinoma; Cohort Studies; Contrast Media; Doxorubicin; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Middle Aged; Paclitaxel; Predictive Value of Tests; Treatment Outcome | 2011 |
14 other study(ies) available for gadolinium dtpa and paclitaxel
| Article | Year |
|---|---|
Molecular imaging and targeted drug delivery with a novel, ligand-directed paramagnetic nanoparticle technology.
Topics: Animals; Antibodies, Monoclonal; Contrast Media; Doxorubicin; Drug Delivery Systems; Emulsions; Fluorocarbons; Gadolinium DTPA; Ligands; Magnetic Resonance Imaging; Muscle, Smooth, Vascular; Nanotechnology; Paclitaxel; Particle Size; Rabbits; Swine | 2002 |
Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosis.
Topics: Animals; Antibodies; Antineoplastic Agents, Phytogenic; Cell Count; Cell Division; Cell Membrane; Cells, Cultured; Contrast Media; Coronary Restenosis; Delayed-Action Preparations; Dose-Response Relationship, Drug; Doxorubicin; Drug Carriers; Drug Delivery Systems; Fluorine Compounds; Fluorocarbons; Gadolinium DTPA; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Muscle, Smooth, Vascular; Oleic Acid; Oleic Acids; Paclitaxel; Particle Size; Swine; Thromboplastin | 2002 |
Measurement of volumetric and vascular changes with dynamic contrast enhanced MRI for cancer therapy monitoring.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Contrast Media; Docetaxel; Female; Gadolinium; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Paclitaxel; Radiography; Rats; Rats, Inbred F344; Taxoids; Time Factors; Treatment Outcome | 2002 |
Accuracy of tumor size measurement in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapy.
Topics: Antineoplastic Agents; Breast; Breast Neoplasms; Contrast Media; Cyclophosphamide; Epirubicin; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Remission Induction | 2003 |
Convection-enhanced drug delivery: increased efficacy and magnetic resonance image monitoring.
Topics: Animals; Brain; Carboplatin; Catheters, Indwelling; Convection; Drug Delivery Systems; Drug Monitoring; Gadolinium DTPA; Magnetic Resonance Imaging; Paclitaxel; Rats; Rats, Sprague-Dawley; Serum Albumin; Viscosity | 2005 |
Paclitaxel encapsulated in cationic lipid complexes (MBT-0206) impairs functional tumor vascular properties as detected by dynamic contrast enhanced magnetic resonance imaging.
Topics: Animals; Antineoplastic Agents, Phytogenic; Capsules; Contrast Media; Cricetinae; Gadolinium DTPA; Lipids; Magnetic Resonance Imaging; Melanoma; Neoplasm Transplantation; Neovascularization, Pathologic; Paclitaxel; Skin Neoplasms; Tumor Cells, Cultured | 2006 |
Predicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy with and without sequential trastuzumab.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Carboplatin; Contrast Media; Cyclophosphamide; Doxorubicin; Female; Gadolinium DTPA; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Mastectomy; Mastectomy, Segmental; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Predictive Value of Tests; Receptor, ErbB-2; Retrospective Studies; Sensitivity and Specificity; Trastuzumab; Treatment Outcome | 2007 |
Preliminary study of the use of drug-eluting stents in atherosclerotic renal artery stenoses 4 mm in diameter or smaller.
Topics: Aged; Aged, 80 and over; Angiography; Drug-Eluting Stents; Female; Gadolinium DTPA; Humans; Immunosuppressive Agents; Male; Middle Aged; Paclitaxel; Proportional Hazards Models; Recurrence; Renal Artery Obstruction; Retrospective Studies; Sirolimus; Stents; Treatment Outcome; Tubulin Modulators; Ultrasonography; Vascular Resistance | 2008 |
Breast cancer: evaluation of response to neoadjuvant chemotherapy with 3.0-T MR imaging.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Carboplatin; Contrast Media; Cyclophosphamide; Doxorubicin; Female; Gadolinium DTPA; Humans; Image Interpretation, Computer-Assisted; Ki-67 Antigen; Magnetic Resonance Imaging; Middle Aged; Neoadjuvant Therapy; Neoplasm, Residual; Neoplasms, Hormone-Dependent; Paclitaxel; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Sensitivity and Specificity; Trastuzumab; Treatment Outcome | 2011 |
Heterogeneity of tumor vasculature and antiangiogenic intervention: insights from MR angiography and DCE-MRI.
Topics: Albumins; Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Contrast Media; Female; Gadolinium DTPA; Humans; Magnetic Resonance Angiography; Mice; Mice, SCID; Neovascularization, Pathologic; Paclitaxel; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2014 |
MRI-guided liposomes for targeted tandem chemotherapy and therapeutic response prediction.
Topics: Animals; Antineoplastic Agents; Carboplatin; Cell Death; Cell Line, Tumor; Drug Delivery Systems; Gadolinium DTPA; Humans; Liposomes; Magnetic Resonance Imaging; Mice, Inbred BALB C; Paclitaxel; Treatment Outcome | 2016 |
Value of intravoxel incoherent motion and dynamic contrast-enhanced MRI for predicting the early and short-term responses to chemoradiotherapy in nasopharyngeal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carcinoma; Chemoradiotherapy; Contrast Media; Diffusion Magnetic Resonance Imaging; Dose Fractionation, Radiation; Female; Gadolinium DTPA; Humans; Induction Chemotherapy; Male; Middle Aged; Nasopharyngeal Neoplasms; Neoplasm, Residual; Organoplatinum Compounds; Paclitaxel; Perfusion; Predictive Value of Tests; ROC Curve; Time Factors; Treatment Outcome | 2016 |
Accuracy of 3-T MRI for Preoperative T Staging of Esophageal Cancer After Neoadjuvant Chemotherapy, With Histopathologic Correlation.
Topics: Adult; Aged; Chemotherapy, Adjuvant; Contrast Media; Esophageal Neoplasms; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Staging; Organoplatinum Compounds; Paclitaxel; Prospective Studies | 2019 |
Histogram analysis of DCE-MRI for chemoradiotherapy response evaluation in locally advanced esophageal squamous cell carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Chemoradiotherapy; Cisplatin; Contrast Media; Esophageal Squamous Cell Carcinoma; Female; Gadolinium DTPA; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Paclitaxel; Radiotherapy Dosage; Retrospective Studies | 2020 |